English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [401]
News [1229]
Articles [147]
Editorials [6]
Conferences [75]
elearning [26]
ASCO 2025: Adding nivolumab to chemoradiotherapy after surgery can decrease chance of recurrence in head and neck cancer
ASCO 2025: Adding nivolumab to chemoradiotherapy after surgery can decrease chance of recurrence in head and neck...
ASCO 2025: Pembrolizumab gives head and neck cancer patients extra years disease-free
ASCO 2025: Pembrolizumab gives head and neck cancer patients extra years disease-free
ASCO 2025: Alcohol-fueled cancer deaths are on the rise in the US
ASCO 2025: Alcohol-fueled cancer deaths are on the rise in the US
Stratifying the immune landscape of tongue cancer
Stratifying the immune landscape of tongue cancer
New blood test developed shows superior sensitivity in detecting HPV-associated head and neck cancers
New blood test developed shows superior sensitivity in detecting HPV-associated head and neck cancers
New method of taxol production has the potential to greatly reduce the cost
New method of taxol production has the potential to greatly reduce the cost
Targeting epigenetics: new insights into oral cancer progression and treatment
Targeting epigenetics: new insights into oral cancer progression and treatment
Scientists develop super strong antibodies for new cancer treatment
Scientists develop super strong antibodies for new cancer treatment
A new CAR-T therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma
A new CAR-T therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma
AACR 2025: Immunotherapy gives head and neck cancer patients extra years disease free
AACR 2025: Immunotherapy gives head and neck cancer patients extra years disease free
<12345...123>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top